Skin manifestation in COVID-19 infection: a thousand appearances (immune response perspective)

Yohanes Firmansyah; Jessica Elizabeth; Sukmawati Tansil Tan

doi:10.18203/issn.2455-4529.IntJResDermatol20204566

Authors

Yohanes Firmansyah Department of Dermatovenerology, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
Jessica Elizabeth Department of Dermatovenerology, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia
Sukmawati Tansil Tan Department of Dermatovenerology, Faculty of Medicine, Tarumanagara University, Jakarta, Indonesia

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20204566

Keywords:

COVID-19, Skin manifestation, Maculopapular, Urticaria, NLR, ALC

Abstract

The clinical manifestations of COVID-19 infection are still unclear. The spectrum of the disease is very broad, with many target organs; one of them is skin. Various skin manifestations have been observed in COVID-19 patients. However, the observed skin manifestation was not specific. This following case series aims to provide an overview of skin manifestations in COVID-19 to help recognize the initial symptoms of COVID-19 infection. This case series also compares cases with and without skin manifestations. This case series discusses seven cases, which the patient had close contact, who had been diagnosed with confirmed COVID-19 by polymerise chain reaction (PCR) examination. The clinical symptoms were mild, such as fever, cough, sore throat, myalgia, malaise, headache, and skin lesions. There are few differences in in complete blood laboratories. Radiology features within normal limits. All patients were given a treatment regimen according to the Indonesian lung association recommendations and symptomatic drugs. Three of seven cases had skin manifestation, which two of them had a maculopapular lesion, and the other one had urticaria lesions. Subjective symptoms, such as itching and burning sensation, were reported. The majority of lesions were localized on the upper and lower limb. Also, in this following case series, there is a tendency for complete blood parameters, neutrophil-to-lymphocyte ratio (NLR), and absolute lymphocyte count (ALC) to be lower in mild cases of confirmed COVID-19 with skin manifestations. It can be concluded that COVID-19 infection may result in skin manifestation with various clinical presentations. This important manifestation may help in diagnosing and treating COVID-19 and prevent further transmission.

Metrics

Metrics Loading ...

References

Jones T, Nahal D. Beating the Pandemic : What Emergency Providers Should Know About COVID-19. Pediatr Emerg Med Reports. 2020.

Du B, Qiu HB, Zhan X, Wang YS, Kang HYJ, Li XY et al. Pharmacotherapeutics for the new coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;12;43(3):173-6.

Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Gulyaeva AA, Haagmans BL et al. The species and its viruses-a statement of the Coronavirus Study Group. Biorxiv. Cold Spring Harb Lab. 2020.

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. 2020. Available at: https://covid19.who.int/?gclid=CjwKCAjw5p_8BRBUEiwAPpJO67kCiZ1Z0nvV1tj94mikV9mitde615ruU8pB6g9TDAMx1t1ST9wEphoCm5gQAvD_BwE.

Indonesia Ministry of Health. COVID-19 Situation. Indonesia Ministry of Health. 2020. Available at: https://covid19.kemkes.go.id/category/situasi-infeksi-emerging/info-corona-virus.

Indonesia Ministry of Health. Guideline for Coronavirus Disease (COVID-19). Directorate General of Disease Prevention and Control. 2020. Available at: https://infeksiemerging.kemkes.go.id/download/REV-04_Pedoman_P2_COVID-19__27_Maret2020_TTD1.pdf.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;15;395(10223):497-506.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.

Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9(1):29

J Jin ZJ, Dong X, Yuan CY, Dong YY, Bin YY, Qin YY et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020;75(7):1730-41.

Song JY, Yun JG, Noh JY, Cheong HJ, Kim WJ. COVID-19 in South Korea Challenges of Subclinical Manifestations. N Engl J Med. 2020;382:1199-207.

Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 202;413:116832.

Zhou Y, Li W, Wang D, Mao L, Jin H, Li Y et al. Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management. Stroke Vasc Neurol. 2020;5(2):177-9.

Kotfis K, Williams RS, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care. 2020;24(1):176.

Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843-51.

Cheong J, Bartell N, Peeraphatdit T, Mosli M, Al-Judaibi B. Gastrointestinal and liver manifestations of COVID-19. Saudi J Gastroenterol. 2020;26:226-32.

Sinonquel P, Roelandt P, Demedts I, van Gerven L, Vandenbriele C, Wilmer A et al. COVID-19 and gastrointestinal endoscopy: what should be taken into account? Dig Endosc. 2020.

Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ. Gastrointestinal and Liver Manifestations of COVID-19. J Clin Exp Hepatol. 2020;10(3):263-5.

Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? Arab J Gastroenterol. 2020;21(1):3-8.

Wong SH, Lui RN, Sung JJ. Covid‐19 and the digestive system. J Gastroenterol Hepatol. 2020;35(5):744-8.

Puliatti S, Eissa A, Eissa R, Amato M, Mazzone E, Dell' Oglio P et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int. 2020;125(6):E7-14

Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132-41.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8.

Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):247-50.

Yang Z, Wang M, Zhu Z, Liu Y. Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review. J Matern Neonatal Med. 2020;1-4.

Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. Int J Gynecol Obstet. 2020;150(1):47-52.

Zhao X, Jiang Y, Zhao Y, Xi H, Liu C, Qu F et al. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis. 2020;1-3.

Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(2): 100107.

Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi D, Veraldi S et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;98(2):75-81.

Wollina U, Karadağ AS, Rowland‐Payne C, Chiriac A, Lotti T. Cutaneous Signs in COVID‐19 Patients: A Review. Dermatol Ther. 2020;13549.

Wollina U. Challenges of COVID‐19 pandemic for dermatology. Dermatol Ther. 2020;13430.

Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, Jimenez-Gomez N, Fernandez-Nieto D. Varicella-like exanthem as a specific COVID-19–associated skin manifestation: multicenter case series of 22 patients": Discussing specificity. J Am Acad Dermatol. 2020;83(1).

Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280-5.

Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177.

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):212-13.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020;34(6):e252-e254.

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020.34(6):250-51.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34(6):544-45.

Kamali Aghdam M, Jafari N, Eftekhari K. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infect Dis (Auckl). 2020;52(6):427-9.

Mazzotta F, Troccili T. Acute Acro-Ischemia in the Child At the Time of COVID-19. Dermatología Pediatr. 2020;30(2):71-4.

Alramthan A, Aldaraji W. A case of COVID‐19 presenting in clinical picture resembling chilblains disease. First report from the Middle East. Clin Exp Dermatol. 2020;45(6):746-8.

Najarian DJ. Morbilliform Exanthem Associated with COVID-19. JAAD Case Reports. 2020;6(6):493-4.

Drago F, Paolino S, Rebora A, Broccolo F, Drago F, Cardo P et al. The challenge of diagnosing atypical exanthems: A clinico-laboratory study. J Am Acad Dermatol. 2012;67(6):1282-8.